期刊文献+

FOLFOX4方案治疗晚期胃癌临床观察 被引量:2

Clinical study of FOLFOX4 regimen in the treatment of advanced gastric cancer
原文传递
导出
摘要 目的观察FOLFOX4方案治疗晚期胃癌的近期疗效和毒副反应。方法42例晚期胃癌患者接受FOLFOX4方案化疗,奥沙利铂85mg/m2,静脉滴注2h,d1;醛氢叶酸200mg/m2,静脉滴注2h,d1、d2;氟尿嘧啶400mg/m2,快速静脉滴注,d1、d2,600mg/m2,持续静脉滴注22h,d1、d2。每2周重复。4个周期后以WHO实体瘤疗效评定标准评价疗效及毒副反应。结果全组42例均可评价疗效,其中完全缓解(CR)1例,部分缓解(PR)19例,稳定(SD)14例,进展(PD)8例,总有效率(CR+PR)47.6%。中位肿瘤进展时间(TTP)为6个月,中位生存时间(MST)为9.5个月。毒副反应主要是骨髓抑制,白细胞降低发生率达80.9%,其次为胃肠道反应,恶心呕吐发生率78.6%,口腔黏膜炎19.0%,腹泻21.4%,无Ⅲ/Ⅳ度胃肠道反应;周围神经毒性发生率为66.7%。结论FOLFOX4方案治疗晚期胃癌的近期疗效较好,毒副反应可以耐受。 Objective To evaluate the efficacy and adverse effects of oxaliplatin(OXA) combined with 5-fluorouracil(5-Fu) and calcium folinate(LV) in the treatment of patients with advanced gastric cancer.Methods Forty-two patients with advanced gastric cancer were treated with FOLFOX4 regimen:OXA 85mg/m^2 iv 2 h,d1;LV 200 mg/m^2 iv 2 h,d1 and d2,followed by 5-Fu 400 mg/m^2 iv bolus and 5-Fu 600 mg/m^2iv 22 h,d1 and d2.The regimen was repeated every 2 weeks.Efficacy and side effects were evaluated after 4 cycles.Results All patients could be evaluated for therapeutic efficacy.One patient achieved compete response(CR),19 patients partial response(PR),14 patients stable disease(SD) and eight patients progression disease(PD),Overall response rate was 47.6%.Median time to progress(TTP) was six months,MST was 9.5 months.The major toxic reactions included nausea,vomiting,leucopenia and peripheral nerve toxicity.Conclusion This study shows that the regimen of FOLFOX 4 is effective and tolerable in advanced gastric cancer.
出处 《中国肿瘤临床与康复》 2010年第1期39-40,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 胃肿瘤/化学疗法 奥沙利铂 氟尿嘧啶 亚叶酸钙 Stomach neoplasm/Chemotherapy Oxaliplatin Fluorouracil Leucovorin
  • 相关文献

参考文献2

二级参考文献21

  • 1吴萍,王理伟,周翡,刘全珍.含草酸铂和含表阿霉素联合方案治疗晚期胃癌的临床观察[J].中华肿瘤防治杂志,2006,13(1):58-60. 被引量:18
  • 2Sasaki T, Maeda Y, Kobayashi T, et al. Standard chemotherapy for gastrointestinal malignancies based on evidence[J]. Jap J Cancer Chemother , 2000,27(20):166-176.
  • 3Findlay M, Cunningham D, Norman A, et al . A phase Ⅱ study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)[J]. Ann Oncol ,1994,5:609-616.
  • 4Cocconi G. Fluorouracil, doxorubicin,and mitomycin combination versus PELF chemotherapy in advanced gastric cancer:a prospective randomized trial of the Italian Oncology Group for Clinical Research[J]. J Clin Oncol ,1994,21(12) :2687.
  • 5Kim YH, Shin SW, Kim BS, et al . Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J]. Cancer , 1999,85:295-301.
  • 6Ajani J. Clinical update on an international phase Ⅱ/Ⅲ docetaxel trial(TAX 325)[J]. Proc Update Meeting on GIC ,2002.
  • 7Kim T, Ahn J,Lee J,et al . A phase Ⅱ trial of capecitabine( X )and cisplantin(P)in previously untreated advanced gastric cancer(AGC)[J]. Proc Am Soc Clin Oncol , 2001,20 : 166.
  • 8金懋林.抗癌新药治疗胃癌进展[A]..抗癌药物与肿瘤化学治疗进展[C].北京:科学出版社,2001.55—64.
  • 9于金明,左文述.现代临床肿瘤学[A].徐世平,吴本俨.APE/Ref-1对细胞因子的凋节及与肿瘤的关系[C].北京:中国科学技术出版社,2006:104-111.
  • 10Kishimoto T,Imamura H,Furukawa H,et al.Chemotherapy for patients with advanced/recurrent gastric cancer and the practice at our institute[J].Gan to Kagaku Ryoho,2005,32(11):1682-1684.

共引文献76

同被引文献31

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部